World Federation of Hemophilia
Jun 3, 2025, 08:58
World Federation of Hemophilia (WFH) 2024 Annual Report: Major Advances in Global Care and Access for Bleeding Disorders
The World Federation of Hemophilia (WFH) just posted on X:
“In 2024, the WFH: Increased WGBD identification and diagnosis, enrolled 1st patient in the GeneTherapy Registry and advocated for WHO Essential Medicines updates and more!”
In 2024, the World Federation of Hemophilia (WFH) made remarkable progress in advancing global care and access. These achievements mark a strong step forward in improving lives for people with bleeding disorders around the world.
You can read 2024 WFH Annual Report for more information!
Stay informed with the latest updates in bleeding disorders—read Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis